TelAve News/10553314

CLEVELAND - Sept. 13, 2018 - TelAve -- Recognizing the lack of funding for pediatric medical device development, PediaVascular held a product pitch competition during the Pediatric & Adult Interventional Cardiac Symposium on September 6, in Las Vegas. Five teams of pediatric cardiologists presented their concepts to a panel of interventional cardiology experts. The winning concept was titled Deflectable Hybrid Sheath from a team at Our Lady's Children's Hospital in Crumlin, Ireland. PediaVascular awarded the team an unrestricted $25,000 grant to continue development efforts. The award also included complimentary consultations with regulatory, reimbursement, intellectual property, legal and business experts to assist in product commercialization.

More on TelAve News

• JNN Group Announces Acceptance as CMMI Institute Partner
• Nancy Payne Named Director of Business Development of CheckpointID
• New Doctor of Behavioral Health Admissions Applicant Resources Available
• Digital Media Solutions to Get in the Game with "EndZone Madness" Activation as a Gold Sponsor of 2018 LeadsCon Connect to Convert
• TriboFilm Research Inc. Announces Phase 2 SBIR Grant Award from The National Institutes of Health under Award Number R44EY024461
• At EURETINA 2018, Navigated Retina Laser is Moving into the Next Decade
• Stress Breakthrough Coaching Now Accessible Worldwide to Burned-Out & Stressed-Out Moms

About PediaVascular: PediaVascular is a social venture formed in 2010 to address the lack of pediatric medical devices. In collaboration with fifty pediatric cardiologists PediaVascular developed a series of angiography catheters, introducers and guide wires specifically for children. They are the first and only to receive FDA clearance for pediatric use. To date, over 15,000 babies have been treated globally with PediaVascular's devices.

http://www.pediavascular.com